|
|
News Breaks | | | | October 9, 2012 | | 06:03 EDT |  | SNY | Sanofi's Genzyme announces new data for AUBAGIO and LEMTRADA
Genzyme, a Sanofi company, announced new data from Genzyme's clinical development programs for AUBAGIO, or teriflunomide, and LEMTRADA, and alemtuzumab, will be presented at the 28(th) Congress of the European Committee for Treatment and Research in Multiple Sclerosis, or ECTRIMS, in Lyon, France, October 10-13. "The data to be presented at ECTRIMS are a reflection not only of the comprehensive clinical development programs supporting AUBAGIO and LEMTRADA, but of the unique commitment and substantial progress Genzyme has made to date in bringing forward differentiated therapies in multiple sclerosis," said Genzyme. | |
|
News For SNY From The Last 14 Days Check below for free stories on SNY the last two weeks. |
|
|
| June 19, 2013 | | 13:53 EDT |  | SNY | Sanofi to hold a conference call
 Subscribe for More Information | | | June 18, 2013 | | 08:38 EDT | | SNY | Sanofi management to meet with JPMorgan
Subscribe for More Information | | | June 13, 2013 | | 11:02 EDT | | SNY | Leerink's major pharma analyst holds an analyst/Industry conference call
Subscribe for More Information | | | June 10, 2013 | | 07:20 EDT | | SNY | Biomed to host a conference
Subscribe for More Information | | | 07:03 EDT | | SNY | Sanofi announces FDA approved sBLA for licensure of influenza vaccine
Subscribe for More Information | |
|
|
|
|
|
|
